OTCMKTS:VBIO - Vitality Biopharma Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.46 -0.04 (-8.00 %)
(As of 03/24/2019 06:59 AM ET)
Previous Close$0.46
Today's Range$0.45 - $0.50
52-Week Range$0.04 - $2.33
Volume13,005 shs
Average Volume19,292 shs
Market Capitalization$24.49 million
P/E RatioN/A
Dividend YieldN/A
Beta1.5
Vitality Biopharma, Inc. engages in the development of cannabinoid pharmaceuticals for the treatment of neurological and inflammatory disorders in the United States. The company's products in pipeline include VBX-100, an oral cannabinoid formulation for inflammatory bowel disease, C.difficile-associated diarrhea and colitis, and narcotic bowel syndrome; and VBX-210, a cannabinoid formulation, which is in preclinical studies for the treatment of gastrointestinal conditions. It develops additional cannabinoid product formulations for refractory pain and autism spectrum disorder. The company was formerly known as Stevia First Corp. and changed its name to Vitality Biopharma, Inc. in July 2016. The company was founded in 2007 and is based in Los Angeles, California.

Receive VBIO News and Ratings via Email

Sign-up to receive the latest news and ratings for VBIO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Commercial physical research
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:VBIO
Previous SymbolOTCMKTS:STVF
CUSIPN/A
Phone530-231-7800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$100,000.00
Book Value$0.01 per share

Profitability

Net Income$-4,300,000.00
Net Margins-2,528.42%

Miscellaneous

Employees7
Market Cap$24.49 million
Next Earnings Date6/27/2019 (Estimated)
OptionableNot Optionable

Vitality Biopharma (OTCMKTS:VBIO) Frequently Asked Questions

What is Vitality Biopharma's stock symbol?

Vitality Biopharma trades on the OTCMKTS under the ticker symbol "VBIO."

How were Vitality Biopharma's earnings last quarter?

Vitality Biopharma Inc (OTCMKTS:VBIO) issued its earnings results on Thursday, February, 14th. The company reported ($0.04) earnings per share (EPS) for the quarter. The firm earned $0.10 million during the quarter. Vitality Biopharma had a negative return on equity of 119.95% and a negative net margin of 2,528.42%. View Vitality Biopharma's Earnings History.

When is Vitality Biopharma's next earnings date?

Vitality Biopharma is scheduled to release their next quarterly earnings announcement on Thursday, June 27th 2019. View Earnings Estimates for Vitality Biopharma.

Has Vitality Biopharma been receiving favorable news coverage?

News headlines about VBIO stock have been trending positive recently, InfoTrie Sentiment Analysis reports. The research group rates the sentiment of media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Vitality Biopharma earned a coverage optimism score of 2.1 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 5.0 out of 10, indicating that recent media coverage is somewhat likely to have an impact on the company's share price in the next several days.

Who are some of Vitality Biopharma's key competitors?

What other stocks do shareholders of Vitality Biopharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Vitality Biopharma investors own include Canopy Growth (CGC), Aurora Cannabis (ACBFF), Cronos Group (CRON), OrganiGram (OGRMF), Innovative Industrial Properties (IIPR), Aphria (APHQF), Aurora Cannabis (ACB), Emerald Health Therapeutics (EMHTF), OrganiGram (OGI) and Verastem (VSTM).

Who are Vitality Biopharma's key executives?

Vitality Biopharma's management team includes the folowing people:
  • Mr. Robert T. Brooke, CEO, Sec., Treasurer, Director & Co-Founder (Age 39)
  • Dr. Brandon J. Zipp Ph.D., Scientific Co-Founder and Director of R&D
  • Dr. J. Jeremiah Mann, VP of Operations & Sr. Agronomist
  • Mr. Richard McKilligan, Controller & Counsel (Age 55)
  • Dr. Dong Yuejin, Partner

How do I buy shares of Vitality Biopharma?

Shares of VBIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Vitality Biopharma's stock price today?

One share of VBIO stock can currently be purchased for approximately $0.46.

How big of a company is Vitality Biopharma?

Vitality Biopharma has a market capitalization of $24.49 million and generates $100,000.00 in revenue each year. Vitality Biopharma employs 7 workers across the globe.

What is Vitality Biopharma's official website?

The official website for Vitality Biopharma is http://www.vitality.bio.

How can I contact Vitality Biopharma?

Vitality Biopharma's mailing address is 1901 AVENUE OF THE STARS 2ND FLOOR, LOS ANGELES CA, 90067. The company can be reached via phone at 530-231-7800 or via email at [email protected]


MarketBeat Community Rating for Vitality Biopharma (OTCMKTS VBIO)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  175 (Vote Outperform)
Underperform Votes:  156 (Vote Underperform)
Total Votes:  331
MarketBeat's community ratings are surveys of what our community members think about Vitality Biopharma and other stocks. Vote "Outperform" if you believe VBIO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VBIO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/24/2019 by MarketBeat.com Staff

Featured Article: Trading Ex-Dividend

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel